Click on a filter below to refine your search. Remove a filter to broaden your search.
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Greatest effect seen during both the 12-month intervention and at six-month follow-up among patients at high risk for cardiovascular events
Even after adjusting for socioeconomic factors, environmental factors were independently tied to higher risk.
Although significant associations are seen for both, the associations are more pronounced in women.
Agency’s action could widen access to the drug if more insurance companies decide to cover it
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.
At extreme temperature percentiles, the risk increased for dying from any cardiovascular cause, ischemic heart disease, stroke and heart failure.
An inverse association was seen for mortality from all cardiovascular disease, ischemic heart disease and stroke.
An association was seen in men and women for higher peanut consumption with reduced risks of total stroke, ischemic stroke and cardiovascular disease.
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity